Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
|
Mar 01, 2024
|
Director, Chairman and CEO
|
Form 4
|
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
|
9,002
|
--
|
27,009
|
|
|
Mar 01, 2024
|
Director, Chairman and CEO
|
Form 4
|
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
|
18,137
|
--
|
3,329,127
|
|
|
Mar 01, 2024
|
Director, Chairman and CEO
|
Form 4
|
Grant, award or other acquisition pursuant to Rule 16b-3(d)
|
26,810
|
--
|
3,355,937
|
|
|
Mar 01, 2024
|
Director, Chairman and CEO
|
Form 4
|
Grant, award or other acquisition pursuant to Rule 16b-3(d)
|
26,811
|
--
|
26,811
|
|
|
Mar 01, 2024
|
Director, Chairman and CEO
|
Form 4
|
Grant, award or other acquisition pursuant to Rule 16b-3(d)
|
3,951
|
--
|
3,952
|
|
|
Mar 01, 2024
|
Managing Director
|
Form 4
|
Grant, award or other acquisition pursuant to Rule 16b-3(d)
|
16,500
|
--
|
344,331
|
|
|
Mar 01, 2024
|
Managing Director
|
Form 4
|
Grant, award or other acquisition pursuant to Rule 16b-3(d)
|
10,859
|
--
|
10,859
|
|
|
Mar 01, 2024
|
Managing Director
|
Form 4
|
Grant, award or other acquisition pursuant to Rule 16b-3(d)
|
1,143
|
--
|
1,144
|
|
|
Mar 01, 2024
|
President
|
Form 4
|
Grant, award or other acquisition pursuant to Rule 16b-3(d)
|
13,517
|
--
|
13,517
|
|
|
Mar 01, 2024
|
President
|
Form 4
|
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
|
2,811
|
--
|
5,622
|
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.